120 related articles for article (PubMed ID: 23861802)
1. ADAM33 gene polymorphisms and mortality. A prospective cohort study.
Figarska SM; Vonk JM; van Diemen CC; Postma DS; Boezen HM
PLoS One; 2013; 8(7):e67768. PubMed ID: 23861802
[TBL] [Abstract][Full Text] [Related]
2. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
Figarska SM; Vonk JM; Boezen HM
Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
[TBL] [Abstract][Full Text] [Related]
3. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.
Sadeghnejad A; Ohar JA; Zheng SL; Sterling DA; Hawkins GA; Meyers DA; Bleecker ER
Respir Res; 2009 Mar; 10(1):21. PubMed ID: 19284602
[TBL] [Abstract][Full Text] [Related]
4. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Schouten JP; Boezen HM
Am J Respir Crit Care Med; 2005 Aug; 172(3):329-33. PubMed ID: 15879414
[TBL] [Abstract][Full Text] [Related]
5. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.
Gosman MM; Boezen HM; van Diemen CC; Snoeck-Stroband JB; Lapperre TS; Hiemstra PS; Ten Hacken NH; Stolk J; Postma DS
Thorax; 2007 Mar; 62(3):242-7. PubMed ID: 17090574
[TBL] [Abstract][Full Text] [Related]
6. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.
Figarska SM; Boezen HM; Vonk JM
Eur J Epidemiol; 2012 Nov; 27(11):867-76. PubMed ID: 23054033
[TBL] [Abstract][Full Text] [Related]
7. Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China.
Tan J; Liu AP; Sun C; Bai YF; Lv F
Ann Hum Biol; 2014; 41(1):9-14. PubMed ID: 24191661
[TBL] [Abstract][Full Text] [Related]
8. Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up.
Taghizadeh N; Vonk JM; Boezen HM
PLoS One; 2016; 11(4):e0153310. PubMed ID: 27055053
[TBL] [Abstract][Full Text] [Related]
9. ADAM33 gene polymorphisms in chronic obstructive pulmonary disease.
Pabst S; Pizarro Touron C; Gillissen A; Lennarz M; Tuleta I; Nickenig G; Skowasch D; Grohé C
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):182-6. PubMed ID: 20156753
[TBL] [Abstract][Full Text] [Related]
10. Association of a disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms with the risk of COPD: an updated meta-analysis of 2,644 cases and 4,804 controls.
Zhou DC; Zhou CF; Toloo S; Shen T; Tong SL; Zhu QX
Mol Biol Rep; 2015 Feb; 42(2):409-22. PubMed ID: 25280544
[TBL] [Abstract][Full Text] [Related]
11. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in a disintegrin and metalloprotease 33 gene and the risk of chronic obstructive pulmonary disease: a meta-analysis.
Zhang R; Li H; Zhao H; Chen W; Cheng D
Respirology; 2014 Apr; 19(3):312-20. PubMed ID: 24422987
[TBL] [Abstract][Full Text] [Related]
13. Replication of association between ADAM33 polymorphisms and psoriasis.
Siroux V; Bouzigon E; Dizier MH; Pin I; Demenais F; Kauffmann F;
PLoS One; 2008 Jun; 3(6):e2448. PubMed ID: 18560587
[TBL] [Abstract][Full Text] [Related]
14. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
[TBL] [Abstract][Full Text] [Related]
15. Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population.
Wang X; Li L; Xiao J; Jin C; Huang K; Kang X; Wu X; Lv F
BMC Med Genet; 2009 Dec; 10():132. PubMed ID: 20003279
[TBL] [Abstract][Full Text] [Related]
16. Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China.
Xiao J; Han J; Wang X; Hua D; Su D; Bao Y; Lv F
Mol Biol Rep; 2011 Nov; 38(8):4941-5. PubMed ID: 21161400
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms V4 and T1 of the ADAM33 gene in Venezuelan patients with asthma or chronic obstructive pulmonary disease.
Martínez D; Lema D; Del Carmen Moreno D; Hipólito García A; Valentina Garmendia J; De Sanctis JB
Invest Clin; 2016 Jun; 57(2):176-186. PubMed ID: 28429897
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD.
Budulac SE; Vonk JM; Postma DS; Siedlinski M; Timens W; Boezen MH
PLoS One; 2012; 7(3):e33386. PubMed ID: 22438921
[TBL] [Abstract][Full Text] [Related]
19. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
[TBL] [Abstract][Full Text] [Related]
20. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
